Literature DB >> 7831289

Human immunodeficiency virus type 1 Nef and p56lck protein-tyrosine kinase interact with a common element in CD4 cytoplasmic tail.

S Salghetti1, R Mariani, J Skowronski.   

Abstract

The human immunodeficiency virus type 1 nef gene induces endocytosis of CD4 antigen and disrupts the association between CD4 and p56lck protein-tyrosine kinase (EC 2.7.1.112). We demonstrate that in T cells these effects of the viral protein require a cluster of hydrophobic amino acids in a membrane-proximal region of the CD4 cytoplasmic tail; other amino acids in the C-terminal segment of CD4 cytoplasmic tail also contribute to the interaction. Mutations in CD4 that prevent down-modulation by Nef also decrease CD4 association with p56lck and prevent Nef-induced disruption of CD4-p56lck complexes. Together, the overlap in CD4 sequences required for interaction with Nef and p56lck and the tight correlation between Nef-induced CD4 down-modulation and disruption of CD4-p56lck association suggest that Nef, or cellular factors recruited by Nef, interact with this segment of CD4 to displace p56lck from the complex and induce CD4 endocytosis.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7831289      PMCID: PMC42737          DOI: 10.1073/pnas.92.2.349

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  38 in total

1.  Interaction of the unique N-terminal region of tyrosine kinase p56lck with cytoplasmic domains of CD4 and CD8 is mediated by cysteine motifs.

Authors:  J M Turner; M H Brodsky; B A Irving; S D Levin; R M Perlmutter; D R Littman
Journal:  Cell       Date:  1990-03-09       Impact factor: 41.582

2.  Short related sequences in the cytoplasmic domains of CD4 and CD8 mediate binding to the amino-terminal domain of the p56lck tyrosine protein kinase.

Authors:  A S Shaw; J Chalupny; J A Whitney; C Hammond; K E Amrein; P Kavathas; B M Sefton; J K Rose
Journal:  Mol Cell Biol       Date:  1990-05       Impact factor: 4.272

3.  Advanced mammalian gene transfer: high titre retroviral vectors with multiple drug selection markers and a complementary helper-free packaging cell line.

Authors:  J P Morgenstern; H Land
Journal:  Nucleic Acids Res       Date:  1990-06-25       Impact factor: 16.971

4.  Activators of protein kinase C induce dissociation of CD4, but not CD8, from p56lck.

Authors:  T R Hurley; K Luo; B M Sefton
Journal:  Science       Date:  1989-07-28       Impact factor: 47.728

5.  Regulation of CD4 and CD8 surface expression on human thymocyte subpopulations by triggering through CD2 and the CD3-T cell receptor.

Authors:  M L Blue; J F Daley; H Levine; K R Branton; S F Schlossman
Journal:  J Immunol       Date:  1989-01-15       Impact factor: 5.422

6.  Lymphocyte activation provokes modification of a lymphocyte-specific protein tyrosine kinase (p56lck).

Authors:  J D Marth; D B Lewis; M P Cooke; E D Mellins; M E Gearn; L E Samelson; C B Wilson; A D Miller; R M Perlmutter
Journal:  J Immunol       Date:  1989-04-01       Impact factor: 5.422

7.  The CD4 and CD8 T cell surface antigens are associated with the internal membrane tyrosine-protein kinase p56lck.

Authors:  A Veillette; M A Bookman; E M Horak; J B Bolen
Journal:  Cell       Date:  1988-10-21       Impact factor: 41.582

8.  The CD4 receptor is complexed in detergent lysates to a protein-tyrosine kinase (pp58) from human T lymphocytes.

Authors:  C E Rudd; J M Trevillyan; J D Dasgupta; L L Wong; S F Schlossman
Journal:  Proc Natl Acad Sci U S A       Date:  1988-07       Impact factor: 11.205

9.  Structural features of the cytoplasmic region of CD4 required for internalization.

Authors:  J Shin; C Doyle; Z Yang; D Kappes; J L Strominger
Journal:  EMBO J       Date:  1990-02       Impact factor: 11.598

10.  Engagement of CD4 and CD8 expressed on immature thymocytes induces activation of intracellular tyrosine phosphorylation pathways.

Authors:  A Veillette; J C Zúñiga-Pflücker; J B Bolen; A M Kruisbeek
Journal:  J Exp Med       Date:  1989-11-01       Impact factor: 14.307

View more
  28 in total

1.  Mechanism for down-regulation of CD28 by Nef.

Authors:  T Swigut; N Shohdy; J Skowronski
Journal:  EMBO J       Date:  2001-04-02       Impact factor: 11.598

Review 2.  HIV-1 Nef control of cell signalling molecules: multiple strategies to promote virus replication.

Authors:  Alison L Greenway; Gavan Holloway; Dale A McPhee; Phoebe Ellis; Alyssa Cornall; Michael Lidman
Journal:  J Biosci       Date:  2003-04       Impact factor: 1.826

3.  Simian and human immunodeficiency virus Nef proteins use different surfaces to downregulate class I major histocompatibility complex antigen expression.

Authors:  T Swigut; A J Iafrate; J Muench; F Kirchhoff; J Skowronski
Journal:  J Virol       Date:  2000-06       Impact factor: 5.103

4.  The SH3 domain-binding surface and an acidic motif in HIV-1 Nef regulate trafficking of class I MHC complexes.

Authors:  M E Greenberg; A J Iafrate; J Skowronski
Journal:  EMBO J       Date:  1998-05-15       Impact factor: 11.598

5.  Mechanism of Nef-induced CD4 endocytosis: Nef connects CD4 with the mu chain of adaptor complexes.

Authors:  V Piguet; Y L Chen; A Mangasarian; M Foti; J L Carpentier; D Trono
Journal:  EMBO J       Date:  1998-05-01       Impact factor: 11.598

6.  Separable functions of Nef disrupt two aspects of T cell receptor machinery: CD4 expression and CD3 signaling.

Authors:  A J Iafrate; S Bronson; J Skowronski
Journal:  EMBO J       Date:  1997-02-17       Impact factor: 11.598

7.  Refined solution structure and backbone dynamics of HIV-1 Nef.

Authors:  S Grzesiek; A Bax; J S Hu; J Kaufman; I Palmer; S J Stahl; N Tjandra; P T Wingfield
Journal:  Protein Sci       Date:  1997-06       Impact factor: 6.725

Review 8.  How HIV Nef Proteins Hijack Membrane Traffic To Promote Infection.

Authors:  Cosmo Z Buffalo; Yuichiro Iwamoto; James H Hurley; Xuefeng Ren
Journal:  J Virol       Date:  2019-11-26       Impact factor: 5.103

9.  Functional characterization of human immunodeficiency virus type 1 nef genes in patients with divergent rates of disease progression.

Authors:  N L Michael; G Chang; L A d'Arcy; C J Tseng; D L Birx; H W Sheppard
Journal:  J Virol       Date:  1995-11       Impact factor: 5.103

10.  Inhibition of Nef- and phorbol ester-induced CD4 degradation by macrolide antibiotics.

Authors:  T Luo; S J Anderson; J V Garcia
Journal:  J Virol       Date:  1996-03       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.